Redifferentiation of dedifferentiated chondrocytes in a novel three-dimensional microcavitary hydrogel

J Biomed Mater Res A. 2015 May;103(5):1693-702. doi: 10.1002/jbm.a.35309. Epub 2014 Aug 20.

Abstract

Although chondrocytes exist in native cartilage all over the body, it is still a challenge to use them as therapeutic cells for cartilage tissue engineering (TE) because of their easy dedifferentiation in in vitro culture. An improved culture system to maintain the characteristics of chondrocytes or recover their chondrocytic phenotype should be developed. In this study, we have set up an innovative microcavitary alginate hydrogel in an easy way. We compared this culture system with the conventional hydrogel and found that the microcavitary hydrogel exhibited outstanding superiorities in helping the dedifferentiated chondrocytes recover the capability for synthesizing cartilaginous extracellular matrix. In addition, we explored the correlation between chondrocyte redifferentiation in microcavitary hydrogels and changes in p38 and Erk1/2 activity. Our findings indicated that this microcavitary hydrogel would be a promising culture system to provide sufficient competent cells for cartilage regeneration and TE.

Keywords: chondrocyte; dedifferentiation; microcavitary hydrogel; redifferentiation; signal pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Cartilage, Articular / cytology
  • Cartilage, Articular / drug effects
  • Cartilage, Articular / metabolism
  • Cell Dedifferentiation / drug effects*
  • Chondrocytes / cytology*
  • Chondrocytes / drug effects
  • Chondrocytes / enzymology
  • Collagen Type I / metabolism
  • Collagen Type II / metabolism
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Gene Expression Regulation / drug effects
  • Glycosaminoglycans / metabolism
  • Hydrogel, Polyethylene Glycol Dimethacrylate / pharmacology*
  • Imaging, Three-Dimensional*
  • Immunohistochemistry
  • MAP Kinase Signaling System / drug effects
  • Microspheres*
  • Real-Time Polymerase Chain Reaction
  • Sus scrofa
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • Collagen Type I
  • Collagen Type II
  • Glycosaminoglycans
  • Hydrogel, Polyethylene Glycol Dimethacrylate
  • Extracellular Signal-Regulated MAP Kinases
  • p38 Mitogen-Activated Protein Kinases